Filing Details
- Accession Number:
- 0001651844-15-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-08 17:13:40
- Reporting Period:
- 2015-08-21
- Filing Date:
- 2015-09-08
- Accepted Time:
- 2015-09-08 17:13:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-21 | 10,000 | $2.19 | 2,177,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-21 | 10,000 | $2.10 | 2,187,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-24 | 10,000 | $2.15 | 2,197,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-26 | 10,000 | $2.05 | 2,207,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-27 | 10,000 | $2.11 | 2,217,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-28 | 10,000 | $2.21 | 2,227,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 9,500 | $2.34 | 2,237,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-09-01 | 4,100 | $2.38 | 2,241,150 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-09-02 | 10,000 | $2.45 | 2,251,150 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-09-03 | 16,400 | $2.44 | 2,267,550 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
Billionaire Hedge Funds
